BDMD
What one share of Baird Medical Investment Holdings Limited holds
Surgical and Medical Instruments and Apparatus
We are a specialized healthcare innovator dedicated exclusively to thyroid related diseases. By combining extensive clinical understanding with cutting-edge technologies, we aim to transform traditional thyroid treatment through intelligent, non-invasive solutions.
Baird Medical Investment Holdings Limited’s numbers from its SEC filings, divided by its shares. Results cover the latest fiscal year to 2025-12-31; the balance sheet is as of 2025-12-31.
| Sales | $0.81 |
|---|---|
| Profit | −$0.98 |
| Capex (buildings and equipment) | $0.00 |
| Free cash flow | −$0.05 |
| Cash and investments | $0.01 |
| Debt | $0.28 |
| Book value | $1.02 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2022 | $1.37 | $0.49 | $0.23 | −$0.21 | — | $1.01 |
| 2023 | $1.53 | $0.51 | $0.13 | −$0.18 | — | $1.22 |
| 2024 | $1.70 | $0.57 | $0.13 | −$0.42 | — | $1.55 |
| 2025 | $0.81 | −$0.98 | $0.00 | −$0.05 | — | $1.02 |